publications

Link to NCBI MyBibliography

http://www.ncbi.nlm.nih.gov/sites/myncbi/1-qSnh6a6szkl/bibliography/47140575/public/?sort=date&direction=ascending

Primary Articles

1. Weinshenker D, Garriga G, Thomas JH (1995) Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans. J Neurosci 15:6975-6985. PMID: 7472454.

2. Reiner DJ, Weinshenker D, Thomas JH (1995) Analysis of dominant mutations affecting muscle excitation in Caenorhabditis elegans. Genetics 141:961-976. PMCID: PMC1206858.

3. Weinshenker D, Wei A, Salkoff L, Thomas JH (1999) Block of an ether-a-go-go-like K(+) channel by imipramine rescues egl-2 excitation defects in Caenorhabditis elegans. J Neurosci 19:9831-9840. PMID: 10559392. Figure 5e from this manuscript was selected for the cover of this issue.

4. Szot P, Weinshenker D, White SS, Robbins CA, Rust NC, Schwartzkroin PA, Palmiter RD (1999) Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli. J Neurosci 19:10985-92. PMID: 10594079.

5. Weinshenker D, Rust NC, Miller NS, Palmiter RD (2000) Ethanol-associated behaviors of mice lacking norepinephrine. J Neurosci 20:3157-3164. PMID: 10777779.

6. Weinshenker D, Szot P, Miller NS, Rust NC, White SS Palmiter RD (2001) Genetic Comparison of Seizure Control by Norepinephrine and Neuropeptide Y. J Neurosci 21:7764-7769. PMID: 11567066.

7. Szot P, Weinshenker D, Rho JM, Storey TW, Schwartzkroin PA (2001) Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Res Dev Brain Res 129:211-214. PMID: 11506865.

8. Weinshenker D, Szot P, Miller NS, Palmiter RD (2001) α1 and β2 Adrenoreceptor Agonists Inhibit Pentylenetetrazole-Induced Seizures in Mice Lacking Norepinephrine. J Pharmacol Exp Ther 298:1042-1048. PMID: 11504801.

9. Jasmin L, Tien D, Weinshenker D, Palmiter RD, Green PG, Janni G, Ohara PT (2002) The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline. Proc Nat Acad Sci USA 99:1029-1034. PMCID: PMC117425.

10. Weinshenker D, White SS, Javors MA, Palmiter RD, Szot P (2002) Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo. Brain Res 946:239-246. PMID: 12137927. PMID: 12370425

11. Weinshenker D, Miller NS, Blizinsky K, Laughlin ML, Palmiter RD (2002) Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Nat Acad Sci USA 99:13873-13877. PMCID: PMC129790.

12. Swoap SJ, Weinshenker D, Palmiter RD, Garber G (2004) Dbh(-/-) mice are hypotensive, have altered circadian rhythms, and have abnormal responses to dieting and stress. Am J Physiol Regul Integr Comp Physiol 286:R108-R113. PMID: 12969876.

13. Hohmann JG, Teklemichael DN, Weinshenker D, Wynick D, Clifton DK, Steiner RA (2004) Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin. Mol Cell Biol 24:2978-2985. PMCID: PMC371109.

14. Szot P, Lester M, Laughlin ML, Liles LC, Palmiter RD, Weinshenker D (2004) The anticonvulsant and proconvulsant effects of α2-adrenoreceptor agonists are mediated by distinct populations of α2A-adrenoreceptors. Neuroscience 126:795-803. PMID: 15183527.

15. Tabb K, Szot P, White SS, Liles LC, Weinshenker D (2004) The ketogenic diet does not alter brain expression of orexigenic neuropeptides. Epilepsy Res 62:35-39. PMID: 15519130.

16. Depondt C, Cock HR, Healy DG, Burley MW, Weinshenker D, Wood NW, Goldstein DB, Sisodiya SM (2004) The -1021C->T DBH gene variant is not associated with epilepsy or antiepileptic drug response. Neurology 63:1497-149. PMID: 15505174.

17. Rommelfanger K, Weinshenker D, Miller GW (2004) Reduced MPTP toxicity in norepinephrine transporter knockout mice. J Neurochem 91:1116-1124. PMID: 15569255.

18. Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, O’Dowd BF, George SR, Perreault ML, Mannisto PT, Robinson S, Palmiter RD, Tallerico T (2005) Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci USA 102: 3513-3518. PMCID: PMC548961.

19. Marino MD, Bourdélat-Parks BN, Weinshenker D (2005) Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice. Behav Brain Res 161:197-203. PMID: 15922045.

20. Gottsch ML, Zeng H, Hohmann JG, Weinshenker D, Clifton DK, Steiner RA (2005) Phenotypic analysis of mice deficient in the type 2 galanin receptor (GALR2). Mol Cell Biol 25:4804-4811. PMCID: PMC1140643.

21. Schank JR, Liles LC, Weinshenker D (2005) Norepinephrine is required for the full anticonvulsant effects of valproic acid in mice. Epilepsy Res 65:23-31. PMID: 15955669.

22. Weinshenker D, Wilson MM, Williams KM, Weiss JM, Lamb NE, Twigger SN (2005) A new method for identifying informative genetic markers in selectively bred rats. Mamm Genome 16:784-791. PMID: 16261420.

23. Bourdelat-Parks B, Anderson, GM, Donaldson ZR, Weiss JM, Bonsall RW, Emery MS, Liles LC, Weinshenker D (2005) Effects of dopamine β-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. Psychopharmacology 183:72-80. PMID: 16163519.

24. Schank JR, Ventura R, Puglisi-Allegra S, Alcaro A, Cole CD, Liles LC, Seeman P, Weinshenker D (2006) Dopamine β-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine. Neuropsychopharmacology 31:2221-2230. PMID: 16395294.

25. Swoap SJ, Gutilla MJ, Liles LC, Smith RO, Weinshenker D (2006) The full expression of fasting-induced torpor in mice requires beta-3 adrenergic receptor signaling. J Neurosci 26:241-245. PMID: 16399693.

26. Olson VG, Heusner CL, Bland RJ, During MJ, Weinshenker D, Palmiter RD. (2006) Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science 311:1017-1020. PMID: 16484499.

27. Martillotti J, Weinshenker D, Liles LC, Eagles DA (2006) A ketogenic diet and knockout of the norepinephrine transporter both reduce seizure severity in mice. Epilepsy Res 68:207-211. PMID: 16356685.

28. Ahern T, Javors MA, Eagles DA, Martillotti J, Mitchell HA, Liles LC, Weinshenker D (2006) The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacology 31:730-738. PMID: 16052243.

29. Mitchell HA, Ahern TH, Liles LC, Javors MA, Weinshenker D (2006) The effects of norepinephrine transporter inactivation on locomotor activity in mice. Biol Psych 60:1046-1052. PMID: 16893531.

30. Reiner DJ, Weinshenker D, Tian H, Nishiwaki K, Miwa J, Gruninger T, LeBoeuf B, Thomas JH, Garcia LR (2006) Behavioral genetics of Caenorhabditis elegans unc-103-encoded ERG-like K+ channel. J Neurogenet 20:41-66. PMID: 16807195.

31. Sanders JD, Szot P, Weinshenker D, Happe HK, Bylund DB, Murrin LC (2006) Analysis of brain adrenergic receptors in dopamine β-hydroxylase knockout mice. Brain Res 1109:45-53. PMID: 16854392.

32. Sowden GL, Drucker DJ, Weinshenker D, Swoap SJ (2007) Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor. Am J Physiol Regul Integr Comp Physiol 292:R962-970. PMID: 17038440.

33. Paladini CA, Beckstead MJ, Weinshenker D (2007) Electrophysiological properties of catecholaminergic neurons in the norepinephrine-deficient mouse. Neuroscience 144:1067-1074. PMCID: PMC1847415.

34. Tabb KD, Boss-Williams KA, Weiss JM, Weinshenker D (2007) Rats bred for susceptibility to depression-like phenotypes have higher kainic acid-induced seizure mortality than their depression-resistant counterparts. Epilepsy Res 74:140-146. PMCID: PMC1940038.

35. Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D (2007) Norepinephrine loss produces more profound motor deficits than MPTP in mice. Proc Natl Acad Sci USA 104:13804-13809. PMCID: PMC1959463.

37. Schank JR, Liles LC, Weinshenker D (2008) Norepinephrine signaling through β-adrenergic receptors is critical for expression of cocaine-induced anxiety. Biol Psych 63:1007-1012. PMCID: PMC2405894.

36. Weinshenker D, Ferrucci M, Busceti CL, Biagioni F, Lazzeri G, Liles LC, Lenzi P, Pasquali L, Murri L, Paparelli A, Fornai F (2008) Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioural, and neurotoxic effects of methamphetamine. J Neurochem 105:471-483. PMCID: PMC2610530.

38. Gaval-Cruz M, Schroeder JP, Liles LC, Javors MA, Weinshenker D (2008) Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures. Pharmacol Biochem Behav 89:556-562. PMCID: PMC2386143.

39. Lin Y, Quartermain D, Dunn AJ, Weinshenker D, Stone EA (2008) Possible dopaminergic stimulation of locus coeruleus alpha1-adrenoceptors involved in behavioral activation. Synapse 62:516-523. PMCID: PMC2754581

40. Mitchell HA, Bogenpohl JW, Liles LC, Epstein MP, Bozyczko-Coyne D, Williams M, Weinshenker D (2008) Behavioral responses of dopamine β-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action. Pharmacol Biochem Behav 91:217-222. PMCID: PMC2597705.

41. Swoap SJ, Weinshenker D (2008) Norepinephrine controls both torpor initiation and emergence via distinct mechanisms in the mouse. PLoS One 3:e4038. PMCID: PMC2602851.

42. Rommelfanger KS, MItrano DA, Smith Y, Weinshenker D (2009) Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain. Neuroscience 158:1530-1540. PMCID: PMC2692639.

43. Goldenstein BL, Nelson BW, Xu K, Luger EJ, Pribula JA, Wald JM, O'Shea LA, Weinshenker D, Charbeneau RA, Huang X, Neubig RR, Doze VA (2009) RGS Protein Suppression of G{alpha}o Protein-Mediated {alpha}2A Adrenergic Receptor Inhibition of Mouse Hippocampal CA3 Epileptiform Activity. Mol Pharmacol 75:1222-1230. PMCID: PMC2672807.

44. Xiao Z, Deng PY, Rojanathammanee L, Yang C, Grisanti L, Permpoonputtana K, Weinshenker D, Doze VA, Porter JE, Lei S (2009) Noradrenergic depression of neuronal excitability in the entorhinal cortex via activation of TREK-2 K+ channels. J Biol Chem 284:10980-10991. PMCID: PMC2667783.

45. Gilsbach R, Röser C, Beetz N, Brede M, Hadamek K, Haubold M, Leemhuis J, Philipp M, Schneider J, Urbanski M, Szabo B, Weinshenker D, Hein L (2009) Genetic dissection of alpha2-adrenoceptor functions in adrenergic versus nonadrenergic cells. Mol Pharmacol 75:1160-1170. PMID: 19251826.

46. Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, Weinshenker D, Greene JG, Miller GW (2009) Nonmotor symptoms of Parkinson’s disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci 29:8103-8113. PMCID: PMC2813143.

47. Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G, Ye K (2009) Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem Biol 16:644-656. PMCID: PMC2844702.

48. Yanpallewar SU, Fernandes K, Marathe SV, Vadodaria KC, Jhaveri D, Rommelfanger K, Ladiwala U, Jha S, Muthig V, Hein L, Bartlett P, Weinshenker D, Vaidya VA (2009) α2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment. J Neurosci 30:1096-1109. PMCID: PMC2880491.

49. Moreira CG, Weinshenker D, Sperandio V (2010) QseC mediates Slamonella enterica serovar Typhimurium virulence in vitro and in vivo. Infect Immun 78:914-926. PMCID: PMC2825943.

50. Skinbjerg M, Seneca N, Liow JS, Hong J, Weinshenker D, Pike VW, Halldin C, Sibley DR, Innis RB (2010) Dopamine β-hydroxylase-deficient mice have normal densities of D2 dopamine receptors in the high affinity state based on in vivo PET imaging and in vitro radioligand binding. Synapse 64:699-703. PMCID: PMC2894264.

51. Schroeder JP, Cooper DA, Schank JR, Lyle MA, Gaval-Cruz M, Ogbonmwan YE, Pozdeyev N, Freeman KG, Iuvone PM, Edwards GL, Holmes PV, Weinshenker D (2010) Disulfiram Attenuates Drug-Primed Reinstatement of Cocaine Seeking via Inhibition of Dopamine beta-Hydroxylase. Neuropsychopharmacology 35:2440-2449. PMCID: PMC2956132.

52. Lee SE, Simons SB, Heldt SA, Zhao M, Schroeder JP, Vellano CP, Cowan DP, Ramineni S, Yates CK, Feng Y, Smith Y, Sweatt JD, Weinshenker D, Ressler KJ, Dudek SM, Hepler JR (2010) RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memory. Proc Natl Acad Sci USA 107:16994-16998. PMCID: PMC2947872.

53. Keebaugh AC, Mitchell HA, Gaval-Cruz M, Freeman KG, Edwards GL, Weinshenker D, Thomas JW (2011) PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouse. PLoS One 6:e22381. PMCID: PMC3144895.

54. Rovin ML, Boss-Williams KA, Alisch RS, Ritchie JC, Weinshenker D, West CH, Weiss JM (2012) Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain. Neuropeptides 46:81-91. PMID: 22317959.

55. Mitrano DA, Schroeder JP, Smith Y, Cortright JJ, Bubula N, Vezina P, Weinshenker D (2012) α1-adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology 37:2161-2172. PMCID: PMC3398716. Figure 4b from this manuscript was selected for the cover of this issue.

56. Baker C, Taylor DG, Osuala K, Natarajan A, Molnar PJ, Hickman J, Alam S, Moscato B, Weinshenker D, Ebert SN (2012) Adrenergic deficiency leads to impaired electrical conduction and increased arrhythmic potential in the embryonic mouse heart. Biochem Biophys Res Comm 423:536-541. PMID: 22683331.

57. Epps SA, Tabb KD, Lin SJ, Kahn AB, Javors MA, Boss-Williams KA, Weiss JM, Weinshenker D (2012) Seizure susceptibility and epileptogenesis in a rat model of epilepsy and depression comorbidity. Neuropsychopharmacology 37:2756-2763. PMCID: PMC3499730.

58. Hammerschmidt T, Kummer MP, Terwel D, Martinez A, Gorji A, Pape HC, Rommelfanger KS, Schroeder JP, Stoll M, Schultze J, Weinshenker D, Heneka MT (2012) Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. Biol Psych 73:454-463. PMID: 22883210.

59. Osuala K, Nguyen HL, Martinez C, Weinshenker D, Ebert SN (2012) Adrenergic hormone deficiency leads to increased embryonic retinoic acid concentrations during a critical phase of heart development. Physiol Genomics 44:934-947. PMCID: PMC3472461.

60. Lin SJ, Epps SA, West CH, Boss-Williams KA, Weiss JM, Weinshenker D (2012) Operant psychostimulant self-administration in a rat model of depression. Pharmacol Biochem Behav 103:380-385. PMCID: PMC3494799.

61. Gaval-Cruz M, Liles LC, Iuvone PM, Weinshenker D (2012) Chronic inhibition of dopamine β-hydroxylase facilitates behavioral responses to cocaine in mice. PLoS One 7:e50583. PMCID: PMC3507785.

62. Schroeder JP, Epps SA, Grice TW, Weinshenker D (2013) The selective dopamine β-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior. Neuropsychopharmacology 38:1032-1038. PMCID: PMC3629392.

63. Purcell RH, Papale LA, Makinson CD, Sawyer NT, Schroeder JP, Escayg A, Weinshenker D (2013) Effects of an epilepsy-causing mutation in the SCN1A sodium channel gene on cocaine-induced seizure susceptibility in mice. Psychopharmacology 228:263-270. PMCID: PMC3695079.

64. Epps SA, Kahn AB, Holmes PV, Boss-Williams KA, Weiss JM, Weinshenker D (2013) Antidepressant and anticonvulsant effects of exercise in a rat model of epilepsy and depression comorbidity. Epilepsy Behav 29:47-52. PMCID: PMC3783960.

65. Manvich DF, DePoy LM, Weinshenker D (2013) Dopamine β-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats. J Pharmacol Exp Ther 347:564-573. PMCID: PMC3836309.

66. Zhang Z, Liu X, Schroeder JP, Chan CB, Song M, Yu SP, Weinshenker D, Ye K (2014) 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s disease. Neuropsychopharmacology 39:638-650. PMCID: PMC3895241.

67. Schank JR, King CE, Sun H, Cheng K, Rice KC, Heilig M, Weinshenker D, Schroeder JP (2014) The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking. Neuropsychopharmacology 39:1093-1101. PMCID: PMC3957103

68. Mitrano DA, Pare JF, Smith Y, Weinshenker D (2014) D1-dopamine and α1-adrenergic receptor co-localize in dendrites of the rat prefrontal cortex. Neuroscience 258C:90-100. PMCID: PMC3913162.

69. Heldt SA, Zimmermann K, Parker K, Gaval M, Weinshenker D, Ressler KJ (2014) Bdnf Deletion or TrkB Impairment in Amygdala Inhibits Both Appetitive and Aversive Learning. J Neurosci 34:2444-2450, correction in J Neurosci 34:4756. PMCID: PMC3921419.

70. Kummer MP, Hammerschmidt T, Martinez A, Terwel D, Eichele G, Witten A, Figura S, Stoll M, Schwartz S, Pape HC, Schultze JL, Weinshenker D, Heneka MT (2014) Ear2 deletion causes early memory and learning deficits in APP/PS1 mice. J Neurosci 34:8845-8854. PMCID: PMC4147626.

71. Cooper DA, Kimmel HL, Manvich DF, Schmidt KT, Weinshenker D, Howell LL (2014) Effects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys. J Pharmacol Exp Ther 350:144-152. PMCID: PMC4056266.

72. Barrie ES, Weinshenker D, Verma A, Pendergrass SA, Lange LA, Ritchie MD, Wilson JG, Kuivaniemi H, Tromp G, Carey DJ, Gerhard GS, Brilliant MH, Hebbring SJ, Cubells JF, Pinsonneault JK, Normal GJ, Sadee W (2014) Regulator polymorphisms in human DBH affect peripheral gene expression and sympathetic activity. Circ Res 115:1017-1025. PMCID: PMC4258174.

73. Liu X, Ye K, Weinshenker D (2015) Norepinephrine protects against Aβ toxicity via TrkB. J Alzheimer Dis 44:251-260. PMCID: PMC4714587.

74. Ogbonmwan YE, Sciolino NR, Groves-Chapman JL, Freeman KG, Schroeder JP, Edwards GL, Holmes PV, Weinshenker D (2015) The Galanin Receptor Agonist, Galnon, Attenuates Cocaine-Induced Reinstatement and Dopamine Overflow in the Frontal Cortex. Addict Biol 20:701-713. PMCID: PMC4305031.

75. Sciolino NR, Smith JM, Stranahan AM, Freeman KG, Edwards GL, Weinshenker D, Holmes PV (2015) Galanin mediates features of neural and behavioral stress resilience afforded by exercise. Neuropharmacology 89:255-64. PMCID: PMC4250306.

76. Ogbonmwan YE, Schroeder JP, Holmes PV, Weinshenker D (2015) The effects of post-extinction exercise on cocaine-primed and stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology 232:1395-1403. PMCID: PMC4388768.

77. Shepard KN, Liles LC, Weinshenker D, Liu R (2015) Norepinephrine is necessary for experience-dependent plasticity in the developing mouse auditory cortex. J Neurosci 35:3432-2437. PMCID: PMC4323528.

78. Manvich DF, Stowe TA, Godfrey JR, Weinshenker D (2015) A method for psychosocial stress-induced reinstatement of cocaine seeking in rats. Biol Psychiatry [Epub ahead of print 7/8/15]. PMCID: PMC4706515.

79. Gokhale A, Vrailas-Mortimer A, Larimore J, Comstra HS, Zlatic SA, Werner E, Manvich DF, Iuvone PM, Weinshenker D, Faundez V (2015) Neuronal copper homeostasis instability by genetic defects in dysbindin, a schizophrenia susceptibility factor. Hum Mol Genetic 24:5512-5523. PMCID: PMC4572075.

80. Rose SJ, Yu XY, Heinzer AK, Harrast P, Fan X, Raike RS, Thompson VB, Pare JF, Weinshenker D, Smith Y, Jinnah HA, Hess EJ (2015) A new knockin mouse model of L-DOPA-responsive dystonia. Brain 138:2987-3002. PMCID: MPC4627353.

81. Gaval-Cruz M, Goertz RB, Puttick DJ, Bowles DE, Meyer RC, Hall RA, Paladini CA, Weinshenker D (2016) Chronic loss of noradrenergic tone produces β-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbens. Addict Biol 21:35-48. PMCID: PMC4326638.

82. Cubells JF, Schroder JP, Barrie ES, Manvich DF, Sadee W, Berg T, Mercer K, Stowe TA, Liles LC, Squires KE, Mezher A, Cuertin P, Perdomo DL, Szot P, Weinshenker D (2016) Human bacterial artificial chromosome (BAC) transgenesis fully rescues noradrenergic function in dopamine β-hydroxylase knockout mice. PLoS One 11:e0154864. PMCID: PMC4857931.

83. Gyoneva S, Swanger SA, Zhang J, Weinshenker D, Tranelis SF (2016) Altered motility of plaque-associated microglia in a model of Alzheimer’s disease. Neuroscience [Epub ahead of print 8/25/16]. PMCID: PMC4927418.

84. Moreira CG, Russell R, Mishra AA, Narayanan S, Ritchie JM, Waldor MK, Curtis MM, Winter SE, Weinshenker D, Sperandio V (2016) Bacterial adrenergic sensors regulate virulence of enteric pathogens in the gut. mBio 7.

Reviews

1. Weinshenker D, Szot P (2002) The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol Ther 94:213-233. PMID: 12113799.

2. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder J, Quirion R, Boksa P, Srivastava L, Yanai K, Weinshenker D, Sumiyoshi T (2006) Psychosis pathways converge via D2High dopamine receptors. Synapse 60:319-346. PMID: 16786561.

3. Weinshenker D, Schroeder JP (2006) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433-1451. PMID: 17164822.

4. Rommelfanger KS, Weinshenker D (2007) Norepinephrine: the redheaded stepchild of Parkinson’s disease. Biochem Pharmacol 74:177-190. PMID: 17416354.

5. Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer’s disease. Curr Alzheimer Res 5:342-345. PMID: 18537547.

6. Weinshenker D (2008) The contribution of norepinephrine and orexigenic neuropeptides to the anticonvulsant effect of the ketogenic diet. Epilepsia 49 (Suppl 8):104-107. PMID: 19049603.

7. Weinshenker D, Warren ST (2008) Neuroscience: fragile dopamine. Nature 455:607-608. PMID: 18833269.

8. Gaval-Cruz M, Weinshenker D (2009) Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv 9:175-187. PMCID: PMC2861803.

9. Mitchell HA, Weinshenker D (2010) Good night and good luck: norepinephrine in sleep pharmacology. Biochem Pharmacol 79:801-809. PMCID: PMC2812689.

10. Weinshenker D (2010) Cocaine sobers up. Nat Med 16:969-970. PubMed PMID: 20823878.

11. Epps SA, Weinshenker D (2013) Rhythm and blues: animal models of depression and epilepsy comorbidity. Biochem Pharmacol 85:135-146. PMID: 22940575.

12. Chalermpalanupap T, Kinkead B, Hu WT, Kummer MP, Hammerschmidt T, Heneka MT, Weinshenker D, Levey AI (2013) Targeting norepinephrine in mild cognitive impairment and Alzheimer’s disease. Alzheimers Res Ther 5:21. PMCID: PMC3706916.

13. Schmidt KT, Weinshenker D (2014) Adrenaline rush: The role of adrenergic receptors in stimulant-induced behaviors. Mol Pharmacol 85:640-650. PMCID: PMC3965894.

14. Weinshenker D, Holmes PV (2015) Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin. Brain Res [Epub 11/20/15]. PMID 26607256 (PMC in process).

Book Chapters

1. Weinshenker D (2004) Galanin and neuropeptide Y: Orexigenic neuropeptides link food intake, energy homeostasis, and seizure susceptibility. In Epilepsy and the ketogenic diet (C.E. Stafstrom and J.M. Rho, eds.), Humana, Totawa, NJ, pp. 279-287.

2. Weinshenker D (2008) Treatment, Pharmacological Approaches to: Clonidine. In Encyclopedia of Drugs, Alcohol, and Addictive Behavior, 3rd ed. (P. Korsmeyer and H. Kranzler, eds.), Macmillan Reference USA, Farmington Hills, MI.

3. Weinshenker D (2008) Clone, Cloning. In Encyclopedia of Drugs, Alcohol, and Addictive Behavior, 3rd ed. (P. Korsmeyer and H. Kranzler, eds.), Macmillan Reference USA, Farmington Hills, MI.

4. Weinshenker D, Tabb K, Szot P (2009) Norepinephrine: a molecular link between epilepsy and depression? In Encylopedia of Basic Epilepsy Research (P. Schwartzkroin, ed.), Elsevier, Academic Press.

5. Weinshenker D (2012) Functional Consequences of Locus Coeruleus Degeneration in Alzheimer’s Disease. In Advances in Alzheimer Research (D.K. Lahiri, ed.), Bentham Science Publishers, Oak Park, IL.